To the Editor— Treatment of asystole caused by vagal nerve stimulator
نویسندگان
چکیده
منابع مشابه
‘Runaway’ vagal nerve stimulator: a case of cyclic asystole
A vagal nerve stimulator (VNS) is a device designed to prevent seizures in patients with drug-refractory epilepsy by providing high-frequency (20–30 Hz) electrical stimulation of the left vagus nerve, activating vagal nerve afferent fibers that carry signals to the brain and reduce seizure activity. Similar to a cardiac pacemaker, the device generator is implanted in the left subpectoral area. ...
متن کاملCase report: Vagal nerve stimulation and late onset asystole
Rohit Shankar , Victor Oluwaseyi Olotu *, Nicholas Cole , Heather Sullivan , Caryn Jory c Neuropsychiatry, Epilepsy and Memory Service, Cornwall Partnership NHS Foundation Trust, Chy Govenek, Threemilestone Industrial Estate, Threemilestone, Truro, Cornwall TR4 9LD, United Kingdom Care of the Elderly Department, Royal Cornwall Hospital NHS Trust, Treliske, Truro, Cornwall TR1 3LJ, United Kingdo...
متن کاملQuality of life after vagal nerve stimulator insertion.
AIM Assess quality-of-life after vagal nerve stimulation and determine patient characteristics associated with improvement in quality-of-life. METHODS Sixteen patients (11 children, 5 adults) who had vagal nerve stimulation at our center were studied. Quality-of-life was assessed pre- and post-vagal nerve stimulation using the Quality-of-Life in Childhood Epilepsy questionnaire for children a...
متن کاملfMRI in patients implanted with a vagal nerve stimulator
OBJECTIVE To demonstrate the feasibility and safety of using functional magnetic resonance imaging (fMRI) to determine the blood oxygen level dependent changes (BOLD) in patients undergoing vagal nerve stimulation (VNS) for the treatment of epilepsy. METHODS Four patients with an implanted vagus nerve stimulator had fMRI images acquired during several cycles of intermittent VNS. Blood oxygen ...
متن کاملCardiac Surgery in a Patient with Implanted Vagal Nerve Stimulator
The prevalence of epilepsy worldwide is around 0.5%-2% of the population. Antiepileptic medications are the first line of treatment in most of the cases but approximately 25%-30% epilepsy patients are refractory to the single or combination therapy. The surgical option for temporal lobe epilepsy is temporal lobectomy, which has its inherent risk of neurological deficits after the surgery. Patie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HeartRhythm Case Reports
سال: 2018
ISSN: 2214-0271
DOI: 10.1016/j.hrcr.2018.06.016